{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:51:52Z","timestamp":1784069512429,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":35,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003973","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T22:16:55Z","timestamp":1069453015000},"source":"Crossref","is-referenced-by-count":27,"title":["Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles"],"prefix":"10.1002","author":[{"given":"Lars W","family":"Westergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick MM","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulco","family":"Van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,20]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003973-BIB1|cit1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(02)03250-8","article-title":"Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization\/intracytoplasmic sperm injection cycles: a randomized, comparative trial.","volume":"78","year":"2002","journal-title":"Fertility & Sterility"},{"issue":"2","key":"10.1002\/14651858.CD003973-BIB2|cit2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomized prospective assesor-blind evaluation of luthenizing hormone dosage and invitro fertilization outcome","volume":"75","author":"Gordon","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"11","key":"10.1002\/14651858.CD003973-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/humrep\/13.11.2995","article-title":"A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients","volume":"13","author":"Jansen","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB4|cit4","series-title":"11th World Congress on In Vitro Fertilization and Human Genetics","first-page":"379","article-title":"Comparison of four different gonadotropins for avarian stimulation in IVF treatment","author":"Kornilov","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD003973-BIB5|cit5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/humrep\/16.2.319","article-title":"HMG is as good as recombinant FSH in terms of oocyte and embryo quality: a prospective randomized trial","volume":"16","author":"Ng","year":"2001","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB6|cit6","series-title":"Human Reproduction Abstracts from the 16th Annual Meeting of ESHRE","first-page":"143","article-title":"Comparison between human menopausal gonadotrophin and recombinant FSH for ovarian stimulation in patients undergoing in-vitro fertilization","author":"Serhal","year":"2000"},{"issue":"2","key":"10.1002\/14651858.CD003973-BIB7|cit7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(00)01696-4","article-title":"Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome","volume":"75","author":"Strehler","year":"2001","journal-title":"Fertility & Sterility"},{"issue":"3","key":"10.1002\/14651858.CD003973-BIB8|cit8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","article-title":"Human menopausal gonadotrophin versus recombinant follicle-stimulating hormone in normogonadotrophic women down-regulated with a gonadotrophin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic sperm injection: a prospective randomized study","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB9|cit9","first-page":"431","article-title":"Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH\/LH ratios. II. Comparison of hMG and recombinant FSH","volume":"42","author":"Duijkers","year":"1997","journal-title":"International Journal of Fertility and Women's Medicine"},{"key":"10.1002\/14651858.CD003973-BIB10|cit10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0015-0282(99)00519-1","article-title":"Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis","volume":"73","author":"Agrawal","year":"2000","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/oxfordjournals.humrep.a136154","article-title":"The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone","volume":"10","author":"Balasch","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB12|cit12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0015-0282(00)00660-9","article-title":"The challenge of meta-analysis and the need to register clinical trials [letter]","volume":"74","author":"Balasch","year":"2000","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/oxfordjournals.humrep.a137513","article-title":"Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process","volume":"6","author":"Chappel","year":"1991","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB14|cit14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0015-0282(16)57734-6","article-title":"Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis","volume":"64","author":"Daya","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/humrep\/14.9.2207","article-title":"Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction","volume":"14","author":"Daya","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB16|cit16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0015-0282(00)00661-0","article-title":"The challenge of meta-analysis and the need to register clinical trials [letter]","volume":"74","author":"Daya","year":"2000","journal-title":"Fertility & Sterility"},{"issue":"1","key":"10.1002\/14651858.CD003973-BIB17|cit17","article-title":"Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles (Cochrane Review)","author":"Daya","year":"2002","journal-title":"The Cochrane Library"},{"issue":"1","key":"10.1002\/14651858.CD003973-BIB18|cit18","article-title":"Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles (Cochrane Review)","author":"Daya","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD003973-BIB19|cit19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003973-BIB20|cit20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(98)00482-8","article-title":"The role of luteinizing hormone in folliculogenesis and ovulation induction","volume":"71","author":"Filicori","year":"1999","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/oxfordjournals.humrep.a019506","article-title":"Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity","volume":"11","author":"Fleming","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/humrep\/13.7.1788","article-title":"Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone","volume":"13","author":"Fleming","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB23|cit23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","article-title":"A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F(TM)) with highly purified urinary FSH (Metrodin(TM) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection","volume":"15","author":"Frydman","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ: British Medical Journal"},{"key":"10.1002\/14651858.CD003973-BIB25|cit25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/oxfordjournals.humrep.a136610","article-title":"Short term use of an LHRH agonist to treat poor responders entering an in-vitro fertilization programm","volume":"2","author":"Howles","year":"1987","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB26|cit26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1677\/joe.0.1260483","article-title":"Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary","volume":"126","author":"Kobayashi","year":"1990","journal-title":"Journal of Endocrinology"},{"key":"10.1002\/14651858.CD003973-BIB27|cit27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/09513599909167540","article-title":"Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women","volume":"13","author":"Laml","year":"1999","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD003973-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization","volume":"10","author":"Out","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003973-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/humrep\/15.8.1691","article-title":"Ovarian stimulation during assisted reproduction treatment: A comparison of recombinant and highly purified urinary human FSH","volume":"15","author":"Schats","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/oxfordjournals.humrep.a138685","article-title":"Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women","volume":"9","author":"Schoot","year":"1994","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0015-0282(16)54715-3","article-title":"Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients","volume":"56","author":"Shoham","year":"1991","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD003973-BIB33|cit33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.1985.tb01113.x","article-title":"Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase","volume":"92","author":"Stanger","year":"1985","journal-title":"British Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD003973-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/oxfordjournals.humrep.a019357","article-title":"The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women","volume":"11","author":"Westergaard","year":"1996","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003973-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergaard","year":"2000","journal-title":"Human Reproduction"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003973.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000},"record-id":"33498"},{"DOI":"10.1002\/14651858.cd003973.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003973\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:28:22Z","timestamp":1628544502000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003973"}},"subtitle":[],"editor":[{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,1,20]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003973","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD003973.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2003,1,20]]}}}